000 02525cam a2200289 4500500
005 20250121143444.0
041 _afre
042 _adc
100 1 0 _aBarrault, Fabien
_eauthor
700 1 0 _a Dramé, Moustapha
_eauthor
700 1 0 _a Heurgue, Alexandra
_eauthor
700 1 0 _a Piardi, Tullio
_eauthor
700 1 0 _a Bernard-Chabert, Brigitte
_eauthor
700 1 0 _a Hoeffel, Christine
_eauthor
700 1 0 _a Sommacale, Daniele
_eauthor
700 1 0 _a Thiéfin, Gérard
_eauthor
245 0 0 _aGeneral practitioner density is not associated with survival in patients with hepatocellular carcinoma
260 _c2018.
500 _a45
520 _aObjective: To determine if the density of general practitioners (GPs) had an impact on overall survival of patients with hepatocellular carcinoma (HCC) and stage of HCC at initial diagnosis in a North-Eastern region of France. Methods: This retrospective study was performed with 246 consecutive HCC patients referred to a multidisciplinary meeting dedicated to hepatobiliary tumors in the Reims University Hospital from 2012 to 2016. The following data were collected: clinico-biological and radiological data, GP density in patient residence area, stage of HCC at diagnosis, treatment. Survival curves were calculated by Kaplan-Meier method and compared with log-rank test. Results: Fifty-one patients (20.7%) were living in a low GP density area (2.2 to 6.8 GPs/10000 inhabitants) and 195 (79.3%) in a high GP density area (6.8 à 12.6 GPs/10000 inhabitants). Overall survival of patients living in a low GP density area was not statistically different from that of patients living in a high GP density area (median survival of 11.7 and 14.8 months respectively; p = 0.58). The tumor stage at initial diagnosis and the delay between diagnosis and case presentation at the multidisciplinary meeting were not significantly different between high and low GP density areas. Conclusion: In a cohort of patients with HCC referred to a regional multidisciplinary meeting dedicated to hepatobiliary cancers, the GP density in residence area of patients with HCC did not influence significantly their survival nor the stage of HCC at diagnosis.
690 _aepidemiology
690 _ahealthcare disparities
690 _ahepatocellular carcinoma
690 _asurvival
786 0 _nSanté Publique | 30 | 5 | 2018-12-19 | p. 679-687 | 0995-3914
856 4 1 _uhttps://shs.cairn.info/journal-sante-publique-2018-5-page-679?lang=en&redirect-ssocas=7080
999 _c587204
_d587204